Zusammenfassung
Wir berichten über eine 55-jährige Patientin mit einer ausgeprägten eosinophilen Myokarditis und hochgradig eingeschränkter linksventrikulärer Pumpfunktion. Klinisch manifestierte sich die Erkrankung mit reduziertem Allgemeinzustand, zunehmender Belastungsdyspnoe und peripheren Ödemen. Im Blutbild fand sich eine Leukozytose mit ausgeprägter peripherer Eosinophilie (48,8%). Eine endomyokardiale Biopsie zeigte eine massive Infiltration des Myokards mit eosinophilen Granulozyten und Nekrosen. Die Symptome und Laborparameter sprechen am ehesten für ein hypereosinophiles Syndrom. Die Differentialdiagnose eines Churg-Strauss-Syndroms wird diskutiert. Es wurde eine leitliniengerechte medikamentöse Herzinsuffizienztherapie sowie immunsuppressive Therapie mit Prednisolon (Decortin H®, 1,5 mg/kgKG) eingeleitet. Darunter lies sich eine rasche Reduktion der eosinophilen Granulozyten mit Normalisierung des peripheren Blutbildes beobachten, was mit einer deutlichen Verbesserung der klinischen Symptomatik korrelierte. Insbesondere war eine signifikante Zunahme der linksventrikulären Pumpfunktion zu beobachten. Nach langsamer Dosisreduktion auf eine Erhaltungsdosis von 10 mg Prednisolon blieben das klinische Beschwerdebild und Blutbild im Verlauf stabil.
Summary
We report the rare case of a 55-year-old female with massive eosinophilic myocarditis and severe, however reversible, impairment of left ventricular function. The patient presented with reduced physical condition, progressive dyspnea on exertion and peripheral edema. The white blood count revealed a leukocytosis and markedly elevated peripheral blood eosinophilics (48.8%). An endomyocardial biopsy demonstrated massive myocardial infiltration with eosinophilic granulocytes and necrosis. The symptoms and laboratory parameters indicate the presence of a hypereosinophilic syndrome. The differential diagnosis of a Churg-Strauss syndrome is discussed. Medical heart failure treatment according to international guidelines and an immunosuppressive treatment with prednisolone (Decortin H® 1.5 mg/kgBW) were initiated. This therapy led to a dramatic reduction of the eosinophilic granulocyte count and normalization of the peripheral blood count, which correlated with a significant improvement of clinical symptoms. Consistently, an increase of left-ventricular function was observed. Upon successive dose reduction to a maintenance dosage of 10 mg prednisolone, the patient’s clinical status and peripheral blood count remained stable.
Article PDF
Avoid common mistakes on your manuscript.
References
Arima M, Kanoh T, Yamasaki A, Matsuda S, Kasuya H, Sunayama S, Kawai S, Okada R (1998) Eosinophilic myocarditis associated with toxicodermia caused by phenobarbital. Jpn Circ J 62(2):132–135
Bain B (2004) The idiopathic hypereosinophilic syndrome and eosinophilic leukemias. Haematologica 89 (2):133–137
Brito-Babapulle F (2003) The eosinophilias, including the idiopathic hypereosinophilic syndrome. Br J Haematol 121(2):203–223
Churg A (2001) Recent advances in the diagnosis of Churg-Strauss syndrome. Mod Pathol 14(12):1284–1293
Churg A, Brallas M, Cronin SR, Churg J (1995) Formes frustes of Churg-Strauss syndrome. Chest 108 (2):320–323
Chusid MJ, Dale DC, West BC, Wolff SM (1975) The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54(1):1–27
Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, Kutok J, Clark J, Galinsky I, Griffin JD, Cross NC, Tefferi A, Malone J, Alam R, Schrier SL, Schmid J, Rose M, Vandenberghe P, Verhoef G, Boogaerts M, Wlodarska I, Kantarjian H, Marynen P, Coutre SE, Stone R, Gilliland DG (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348(13):1201–1214
Corradi D, Vaglio A, Maestri R, Legname V, Leonardi G, Bartoloni G, Buzio C (2004) Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death. Hum Pathol 35(9):1160–1163
deMello DE, Liapis H, Jureidini S, Nouri S, Kephart GM, Gleich GJ (1990) Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis. N Engl J Med 323(22):1542–1545
Fauci AS, Haynes BF, Katz P, Wolff SM (1983) Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98(1):76–85
Fenoglio JJ Jr, McAllister HA Jr, Mullick FG (1981) Drug related myocarditis. I. Hypersensitivity myocarditis. Hum Pathol 12(10):900–907
Gleich GJ, Leiferman KM, Pardanani A, Tefferi A, Butterfield JH (2002) Treatment of hypereosinophilic syndrome with imatinib mesilate. Lancet 359(9317):1577–1578
Guillevin L, Fain O, Lhote F, Jarrousse B, Le Thi Huong D, Bussel A, Leon A (1992) Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients. Arthritis Rheum 35(2):208–215
Hirasawa M, Deguchi H, Ukimura A, Kitaura Y (2003) Immunologic interaction between infiltrating eosinophils and T lymphocytes in murine spontaneous eosinophilic myocarditis. Int Arch Allergy Immunol 130(1):73–81
Hoppe UC, Erdmann E (2001) Guidelines for the treatment of chronic heart failure. Issued by the Executive Committee of the German Society of Cardiology—Heart and Circulation Research, compiled on behalf of the Commission of Clinical Cardiology in cooperation with Pharmaceutic Commission of the German Physicians’ Association. Z Kardiol 90(3):218–237
Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Jacobs AK, Hiratzka LF, Russell RO, Smith SC Jr (2001) ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 104(24):2996–3007
Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348(20):2007–2018
Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33(8):1094–1100
Morita H, Kihara T, Tatsumi Y, Kitano Y, Sagami S (1992) Allergic granulomatosis and angiitis of Churg-Strauss. A case of high serum level of eosinophil cationic protein. Acta Derm Venereol 72(3):201–202
Nakagawa C, Sakaguchi Y, Nakajima T, Kawamoto A, Uemura S, Fujimoto S, Hashimoto T, Dohi K, Shirai T (1999) A case of eosinophilic myocarditis complicated by Kimura’s disease (eosinophilic hyperplastic lymphogranuloma) and erythroderma. Jpn Circ J 63(2):141–144
Noth I, Strek ME, Leff AR (2003) Churg-Strauss syndrome. Lancet 361 (9357):587–594
Olsen EG, Spry C (1985) Relation between eosinophilia and endomyocardial disease. Prog Cardiovasc Dis 27(4):241–254
Pardanani A, Reeder T, Porrata LF, Li CY, Tazelaar HD, Baxter EJ, Witzig TE, Cross NC, Tefferi A (2003) Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders. Blood 101(9):3391–3397
Pardanani A, Tefferi A (2004) Imatinib therapy for hypereosinophilic syndrome and eosinophilia-associated myeloproliferative disorders. Leuk Res 28(Suppl 1):S47–52
Remme WJ, Swedberg K (2001) Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22(17):1527–1560
Tuggey JM, Hosker HS (2000) Churg-Strauss syndrome associated with montelukast therapy. Thorax 55(9):805–806
Weller PF, Plaut M, Taggart V, Trontell A (2001) The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report. J Allergy Clin Immunol 108(2):175–183
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huntgeburth, M., Lindner, M., Fries, J.W.U. et al. Hypereosinophilic syndrome associated with acute necrotizing myocarditis and cardiomyopathy. ZS Kardiologie 94, 761–766 (2005). https://doi.org/10.1007/s00392-005-0288-0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00392-005-0288-0
Schlüsselwörter
- Eosinophilie
- idiopathisches hypereosinophiles Syndrom
- Myokarditis
- Kardiomyopathie
- Endomyokardiale Biopsie
- Steroide